Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 89
Filter
1.
Zhonghua Fu Chan Ke Za Zhi ; 57(7): 519-529, 2022 Jul 25.
Article in Chinese | MEDLINE | ID: mdl-35902786

ABSTRACT

Objective: To investigate the inhibitory effect of combined strategy of poly adenosine diphosphate ribose polymerase (PARP) inhibitor and interleukin-1ß (IL-1ß) inhibitor on homologous recombination deficiency (HRD)-proficient ovarian cancer cells. Methods: (1) HRD-proficient ovarian cancer cell lines OVCAR3 and CAOV3 were treated with PARP inhibitor olaparib. Screening by RNA sequencing analysis, the expression level of IL-1ß was validated by enzyme-linked immunosorbent assay (ELISA) and western blot. (2) The dose-response curves of IL-1ß inhibitor diacerein were evaluated by cell counting kit-8 (CCK-8) assays in OVCAR3 and CAOV3 cells. CCK-8 assays were further applied to determine the viabilities of OVCAR3 and CAOV3 cells. (3) To evaluate the synergistic effects of olaparib and IL-1ß inhibitor in vivo, the transplanted ovarian cancer model was constructed. BALB/c-nude mice (n=16) were injected intraperitoneally with 1×107 OVACR3 cells labelled with luciferase (OVCAR3-Luc). Immunohistochemistry (IHC) assay was performed to determine nuclear antigen associated with cell proliferation (Ki-67) expression. (4) Blood routine tests, kidney and liver function tests were performed to analyze the toxic reaction of different drug treatments. The potential drug-induced injuries of vital organs including heart, liver, spleen, lungs and kidneys of nude mice were determined by hematoxylin-eosin (HE) staining. Results: (1) The RNA sequencing results showed that the mRNA level of IL-1ß was the most significantly increased among the 25 differentially expressed genes in OVCAR3 cells treated with olaparib, compared to the negative control group. Olaparib treatment significantly promoted the secretion and expression of IL-1ß protein in both OVACR3 and CAOV3 cells by ELISA [(36.2±3.5) and (49.5±3.5) pg/ml, respectively; all P<0.001] and western bolt (2.87±0.37 and 2.05±0.08, respectively; all P<0.01). (2) The half maximal inhibitory concentration (IC50) value of IL-1ß inhibitor was determined as follows: 75 µmol/L for OVACR3 cells and 100 µmol/L for CAOV3 cells. The treatments were divided into four groups including control group, olaparib monotherapy group, IL-1ß inhibitor monotherapy group and the combination therapy group. The cell viabilities of each group in OVCAR3 and CAOV3 were determined by CCK-8 assay. The data in each group were showed as follows for OVCAR3 and CAOV3 cells: (100.0±0.4)% and (100.0±3.5)% in control group; (63.1±6.2)% and (63.3±3.8)% in olaparib monotherapy group; (61.6±4.7)% and (63.8±3.5)% in IL-1ß inhibitor monotherapy group; and (32.9±5.2)% and (30.0±1.3)% in the combination therapy group. The viability assay showed that the combined strategy exhibited a significant inhibition effect on OVACR3 and CAOV3 cells, compared to the monotherapy group and the control group (all P<0.01). (3) All mice with transplanted tumors of HRD-proficient ovarian cancer cells were randomly divided into four groups, and treated with four different treatments as mentioned above, respectively. After 4 weeks (on day 29), the vivo fluorescence imaging were determined. The results showed that the amount of fluorescence of transplanted tumors was mostly decreased in the combination therapy group [(0.5±0.4)×1010 p/s], compared to the control group [(4.2±1.0)×1010 p/s] or the groups treated with any single drug [(3.1±0.9)×1010, (2.2±0.9)×1010 p/s; all P<0.05]. Mice were then sacrificed under anesthesia, and all transplanted tumors detached and weighed for further investigation. The weight of transplanted tumors was significantly decreased in the combination therapy group [(0.09±0.03) g], compared to that in control group [(0.25±0.05) g] or groups treated with any single drug [(0.17±0.03), (0.19±0.04) g; all P<0.05]. The measurement of the expression of Ki-67 showed that it was significantly decreased in the combination therapy group (0.33±0.10), compared to that in the control group (1.00±0.20) or monotherapy groups (0.76±0.07, 0.77±0.12; all P<0.05). (4) There were no significant differences of body weights, blood routine test, renal and liver function tests among mice with different treatments (all P>0.05). Moreover, no significant injuries were observed in the vital organs among the four groups. Conclusions: The combination of olaparib and IL-1ß inhibitor synergistically exhibits significant cytotoxicity in HRD-proficient ovarian cancer cells. Moreover, the blood routine and blood biochemistry results confirmed the biosafety of the combination of olaparib and IL-1ß inhibitor.


Subject(s)
Ovarian Neoplasms , Animals , Apoptosis , Carcinoma, Ovarian Epithelial , Cell Line, Tumor , Female , Homologous Recombination , Humans , Ki-67 Antigen , Mice , Mice, Nude , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/genetics , Ovarian Neoplasms/pathology , Phthalazines , Piperazines
2.
Zhonghua Liu Xing Bing Xue Za Zhi ; 43(4): 509-516, 2022 Apr 10.
Article in Chinese | MEDLINE | ID: mdl-35443305

ABSTRACT

Objective: To understand the prevalence of osteoporosis and related factors in postmenopausal women aged ≥40 years in China and provide scientific evidence for osteoporosis prevention and control. Methods: Data of this study were from the 2018 China Osteoporosis Epidemiological Survey, covering 44 counties (districts) in 11 provinces in China. Related variables were collected by questionnaire survey and physical measurement, and the BMD of lumbar spine and proximal femur was measured by dual-energy X-ray absorption method. The prevalence of osteoporosis and its 95%CI in postmenopausal women aged ≥40 years were estimated with complex sampling weights. Results: A total of 5 728 postmenopausal women aged ≥40 years were included in the analysis and the prevalence of osteoporosis was 32.5% (95%CI: 30.3%-34.7%). The prevalence of osteoporosis in postmenopausal women aged 40-49 years, 50-59 years, 60-69 years, 70-79 years, and ≥80 years were 16.0% (95%CI:4.5%-27.5%), 18.4% (95%CI:15.9%-20.8%), 37.5% (95%CI:34.5%-40.4%), 52.9% (95%CI: 47.5%-58.3%), and 68.0% (95%CI:55.9%-80.1%) respectively. The prevalence of osteoporosis was higher (P<0.001) in those with education level of primary school or below (47.2%, 95%CI: 43.0%-51.3%) and in those with individual annual income less than 10 000 Yuan, (40.3%, 95%CI: 36.9%-43.7%). The prevalence of osteoporosis was 35.1% in rural areas (95%CI: 32.0%-38.1%), which was higher than that in urban areas (P<0.001). The prevalence of osteoporosis in low weight, normal weight, overweight and obese groups were 69.9% (95%CI: 59.0%-80.8%), 42.2% (95%CI: 38.7%-45.7%), 24.2% (95%CI: 21.3%-27.1%) and 14.6% (95%CI: 11.1%-18.0%), respectively. The prevalence of osteoporosis in those with menstrual maintenance years ≤30 years and in those with menopause years ≥11 years were 46.1% (95%CI:40.8%-51.3%) and 48.2% (95%CI:45.0%-51.3%), respectively. Multivariate logistic analysis showed that age ≥60 years, education level of primary school or below, annual household income per capita less than 10 000 Yuan, low body weight, menstrual maintenance years ≤30 years, menopause years ≥11 years were risk factors of osteoporosis in postmenopausal women in China. Conclusions: The prevalence of osteoporosis was high in postmenopausal women aged ≥40 years in China, and there were differences in osteoporosis prevalence among different socioeconomic groups. Effective interventions should be taken for the prevention and control of osteoporosis in key groups in the future.


Subject(s)
Osteoporosis, Postmenopausal , Osteoporosis , Absorptiometry, Photon , Bone Density , China/epidemiology , Female , Humans , Lumbar Vertebrae , Osteoporosis/complications , Osteoporosis/epidemiology , Osteoporosis, Postmenopausal/epidemiology , Osteoporosis, Postmenopausal/etiology , Postmenopause , Prevalence , Risk Factors
3.
J Hosp Infect ; 121: 1-8, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34902499

ABSTRACT

BACKGROUND: The COVID-19 pandemic has prompted hospitals to respond with stringent measures. Accurate estimates of costs and resources used in outbreaks can guide evaluations of responses. We report on the financial expenditure associated with COVID-19, the bed-days used for COVID-19 patients and hospital services displaced due to COVID-19 in a Singapore tertiary hospital. METHODS: We conducted a retrospective cost analysis from January to December 2020 in the largest public hospital in Singapore. Costs were estimated from the hospital perspective. We examined financial expenditures made in direct response to COVID-19; hospital admissions data related to COVID-19 inpatients; and the number of outpatient and emergency department visits, non-emergency surgeries, inpatient days in 2020, compared with preceding years of 2018 and 2019. Bayesian time-series was used to estimate the magnitude of displaced services. RESULTS: USD $41.96 million was incurred in the hospital for COVID-19-related expenses. Facilities set-up and capital assets accounted for 51.6% of the expenditure; patient-care supplies comprised 35.1%. Of the 19,611 inpatients tested for COVID-19 in 2020, 727 (3.7%) had COVID-19. The total inpatient- and intensive care unit (ICU)-days for COVID-19 patients in 2020 were 8009 and 8 days, respectively. A decline in all hospital services was observed from February following a raised disease outbreak alert level; most services quickly resumed when the lockdown was lifted in June. CONCLUSION: COVID-19 led to an increase in healthcare expenses and a displacement in hospital services. Our findings are useful for informing economic evaluations of COVID-19 response and provide some information about the expected costs of future outbreaks.


Subject(s)
COVID-19 , Bayes Theorem , COVID-19/epidemiology , Communicable Disease Control , Hospital Costs , Hospitals, Public , Humans , Pandemics , Retrospective Studies , SARS-CoV-2 , Singapore/epidemiology , Tertiary Healthcare
4.
Clin Ter ; 172(4): 278-283, 2021 Jul 05.
Article in English | MEDLINE | ID: mdl-34247211

ABSTRACT

OBJECTIVE: We compared sonoanatomy of the internal jugular vein (IJV) the high (HA), conventional (CA) and the medial oblique approach (MA) to identify the best approach and head position for IJV cannulation. MATERIALS & METHODS: Total of 45 volunteers aged 18-65 years were included in this study. The degree of overlap in percentage, depth of IJV from skin, antero-posterior (AP) and transverse diameters (TD) of IJV were measured in real time with ultrasound (US). Measurements were taken in the HA, CA and MA in neutral and 30° head rotation on both the right and left side of the neck. RESULTS: The HA had lower percentage of overlap when compared to CA and MA in neutral and 30° head rotation (p= 0.002 to ≤0.001). The IJV was more shallow in the CA and MA. The AP and TD of the IJV were larger in the MA when compared to HA (p=<0.001) and CA (p =0.026 to < 0.001) and the right IJV has a larger AP and TD in all approaches. DISCUSSION: The HA had the least percentage of overlap compared to CA and MA, therefore the risk of accidental ICA puncture can be reduced. The apparent overlap seen in MA may not reflect the actual scenario because of the way the US beam cuts the vessel. The AP and TD of IJV were significantly increased in the MA, which would ease CVC. CONCLUSION: We conclude and recommend the medial oblique probe position with 30° head rotation provides optimal real time sonographic parameters for US guided IJV cannulation.


Subject(s)
Catheterization, Central Venous/methods , Jugular Veins/anatomy & histology , Jugular Veins/diagnostic imaging , Rotation , Ultrasonography/methods , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Prospective Studies , Young Adult
5.
Zhonghua Fu Chan Ke Za Zhi ; 56(6): 393-400, 2021 Jun 25.
Article in Chinese | MEDLINE | ID: mdl-34154314

ABSTRACT

Objective: To identify the factors associated with long-term survival and guide the decision for primary surgery in patients with advanced high-grade serous ovarian cancer(HGSOC). Methods: In this case-control study, clinical parameters, including surgical and non-surgical associated factors, were collected and compared between the patients with short-term (<2 years) and long-term (>5 years) survival who all underwent primary debulking surgery (PDS) followed by carboplatin and paclitaxel chemotherapy from January 2004 to December 2016. Univariate analysis was examined by chi-square test and multivariate analysis was performed by logistic regression analysis. Results: There were 95 cases long-term survival (LTS group) and 77 cases short-term survival (STS group) in 698 newly diagnosed HGSOC patients with International Federation of Gynecology and Obstetrics (FIGO) stage Ⅲc and Ⅳ who met include and exclude criteria. (1) Univariate analysis showed that the proportion of complete cytoreduction with no visible residual disease (R0) at PDS and platinum sensitivity in LTS group were significantly higher than those in STS group (P<0.01). The surgical complexity score (SCS), the preoperative serum CA125 level and the ascites volume in the LTS group were significantly lower than those of the STS group (all P<0.05). In the LTS group, the preoperative incidence of lesions in retrograde peritoneum of the bladder, serosal and mesangial membrane of the small intestine, upper abdominal peritoneum and liver parenchyma were significantly lower than those in the STS group (all P<0.05). Multivariate logistic regression analysis showed that platinum sensitivity (OR=0.016, 95%CI: 0.004-0.063, P<0.01), ascites volume >500 ml (OR=3.193, 95%CI: 1.285-7.930, P=0.012), and SCS ≥8 (OR=17.433, 95%CI: 2.281-133.25, P=0.003) were independent factors affecting long-term survival (P>0.05). (2) Totally 37 of 95 in long-term survival and 16 of 77 in short-term survival achieved R0 cytoreduction at PDS. Univariate analysis showed that preoperative serum CA125 level, preoperative lesion score, preoperative lesion (DS) score, ascites volume, platinum sensitivity,and SCS were significantly correlated with the R0 PDS (all P<0.05). Multivariate analysis showed that ascites volume >500 ml (OR=5.199, 95%CI: 2.015-13.409, P=0.001), DS >2 (OR=15.264, 95%CI: 5.843-39.874, P<0.01) and SCS ≥4 (OR=4.176, 95%CI: 1.618-10.777, P=0.003) were independent factors associated with R0 cytoreduction. In patients with DS ≤2 or SCS <4, but not those with DS >2 or SCS ≥4, R0 cytoreduction was significantly associated with long-term survival. Conclusion: The intrinsic biology of tumor is the factor influencing long-term survival of advanced HGSOC patients, and those who present with wide intraperitoneal metastases and need to remove multiple organs may not benefit from R0 cytoreduction.


Subject(s)
Ovarian Neoplasms , Carboplatin , Case-Control Studies , Cytoreduction Surgical Procedures , Female , Humans , Neoplasm Staging , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/pathology , Ovarian Neoplasms/surgery , Paclitaxel , Retrospective Studies
6.
BJS Open ; 3(2): 161-168, 2019 04.
Article in English | MEDLINE | ID: mdl-30957062

ABSTRACT

Background: Society of Surgical Oncology and American Society for Radiation Oncology guidelines define clear margins in breast-conserving therapy (BCT) as 'no ink on tumour', in contrast to the attainment of margins of at least 1 mm widely practised in the UK. The primary aim of this study was to explore clinical, surgical and tumour-related factors associated with local recurrence after BCT, with a secondary aim of assessing the impact of margin re-excision on the risk of local recurrence. Methods: Patient demographics, surgical details, tumour characteristics and local recurrence were recorded for consecutive women with BCT undergoing surgery between January 1997 and January 2007. Margins were defined as clear (greater than 1 mm), close (less than 1 mm but no ink on tumour), reaches (ink on tumour) and clear after re-excision. Results: A total of 1045 women of median age 54 (range 18-86) years were studied. Median follow-up was 89 (range 4-196) months. Local recurrence occurred in 52 patients (5·0 per cent). Ink on tumour was associated with local recurrence (hazard ratio (HR) 4·86, 95 per cent c.i. 1·49 to 15·79; P = 0·009). Risk of local recurrence was the same for close and clear margins (HR 1·03, 0·40 to 2·62; P = 0·954). In women with involved margins, re-excision was still associated with an increased local recurrence risk (HR 2·50, 1·32 to 4·72; P = 0·005). Oestrogen receptor negativity increased risk (HR 2·28, 1·28 to 4·06; P = 0·005). Conclusion: Adequately excised margins, even when under 1 mm, provide equivalent outcomes to wider margins in BCT. Achieving complete excision at primary surgery achieves the lowest rates of local recurrence.


Subject(s)
Breast Neoplasms/therapy , Breast/surgery , Margins of Excision , Mastectomy, Segmental/methods , Neoplasm Recurrence, Local/prevention & control , Adolescent , Adult , Aged , Aged, 80 and over , Breast/pathology , Breast Neoplasms/epidemiology , Breast Neoplasms/mortality , Disease-Free Survival , Female , Follow-Up Studies , Humans , Middle Aged , Neoplasm Recurrence, Local/epidemiology , Radiotherapy, Adjuvant , United Kingdom/epidemiology , Young Adult
7.
Opt Express ; 27(2): 470-482, 2019 Jan 21.
Article in English | MEDLINE | ID: mdl-30696132

ABSTRACT

Molecular emission can be used for isotopic analysis in laser-induced breakdown spectroscopy (LIBS) due to its large isotopic shift. However, spectral weakness and interference have become the main flaws in molecular isotopic analysis, causing deterioration of quantitative accuracy and sensitivity. Here, to overcome these problems, laser-induced radical fluorescence (LIRF) was applied to enhance the molecular spectra and eliminate the spectral interference. The root mean square errors of cross validation (RMSECVs) of boron and carbon isotopes (11BO, 10BO, 12CN, and 13CN) improved to 2.632, 5.721, 5.990, and 1.543 at.%, as compared with 16.96, 35.79, 57.10, and 13.89 at.%, respectively, obtained in the case without LIRF. The limits of detection (LoDs) of 11BO, 10BO, 12CN, and 13CN were 0.9858, 0.8470, 1.606, and 1.193 at.%, respectively. This work demonstrates the feasibility of LIBS-LIRF to achieve isotopic determination with high accuracy and sensitivity.

8.
Opt Express ; 26(3): 2634-2642, 2018 Feb 05.
Article in English | MEDLINE | ID: mdl-29401800

ABSTRACT

Boron is an essential element for industry, but it is hard to accurately and rapidly determine high boron content with conventional laser-induced breakdown spectroscopy (LIBS), due to the matrix and self-absorption effect. Using molecular emission is an alternative method for boron content analysis, but its weak spectra are major challenges. Here, boron monoxide (BO) radicals were used to establish calibration assisted by LIBS and laser-induced radical fluorescence (LIBS-LIRF). Two types of BO radical excitations, vibrational ground state excitation (LIRFG) and vibrational excited state excitation (LIRFE), were compared. The results showed that LIRFG achieved better sensitivity with a limit of detection of 0.0993 wt.%, while the LIRFE was more accurate with a root mean square error of cross validation of 0.2514 wt.%. In conclusion, this work provided a potential approach for molecular emission analysis with LIBS-LIRF.

9.
Bratisl Lek Listy ; 118(10): 609-612, 2017.
Article in English | MEDLINE | ID: mdl-29198128

ABSTRACT

BACKGROUND: Pro-protein processing mechanism plays an important role in neuron injury. OBJECTIVE: To study the protein convertase 1 (PC1) mediated processing mechanism, the ischemic cellular or tissue proPC1/PC1 or proCgA/CgA (pro-chromogranin A) was analyzed. METHODS: NS20Y differentiated cells were stressed by 0-6 h of oxygen and glucose deprivation (OGD) in glucose-free DMEM and an anaerobic jar environment. Ischemic C57BL/J mouse model was established by performing 60-min of middle cerebral artery occlusion (MCAO) operation and subsequent 4 or 24-h reperfusion. The TUNEL, immunochemistry, and Western blot methods were used to detect protein expression in ischemic cells or tissues. RESULTS: The OGD or MCAO stress caused substantial cell death in a dose-dependent manner (p < 0.05 or 0.01). With the increasing OGD dose, proPC1 and PC1 proteins gradually increased (p < 0.05 or 0.01) whereas proCgA and CgA proteins decreased (p < 0.05). In vivo the proPC1 and PC1 expressions presented with a peak at 4-h and then decreased at 24-h reperfusion (p < 0.05 or 0.01). The tissue proCgA and CgA proteins decreased with the increasing reperfusion time (p < 0.05). CONCLUSIONS: The results suggest that the increasing PC1 expression promoted the transformation of proCgA into CgA or smaller peptides, i.e. Pancreastatin or Secretoneurin, and the PC1 mediated processing plays a critical role (Fig. 4, Ref. 15).


Subject(s)
Cell Death , Chromogranin A/metabolism , Infarction, Middle Cerebral Artery/metabolism , Neurons/metabolism , Proprotein Convertase 1/metabolism , Animals , Blotting, Western , Brain Ischemia/metabolism , Cell Differentiation , Cell Hypoxia , Glucose , In Situ Nick-End Labeling , Mice , Mice, Inbred C57BL , Neuropeptides/metabolism , Secretogranin II/metabolism
10.
J Vet Pharmacol Ther ; 39(1): 84-9, 2016 Feb.
Article in English | MEDLINE | ID: mdl-25891823

ABSTRACT

Nanotechnology applications in medicine have seen a tremendous growth in the past decade and are being employed to enhance the stability and bioavailability of lipophilic substances, such as florfenicol. This study aimed to examine the pharmacokinetic properties of the formulated oil-in-water florfenicol-loaded nanoemulsion (FF-NE). FF-NE and florfenicol control (Nuflor) were administered to the pigs at a dose of 20 mg/kg. Nanoemulsion formulation of florfenicol was highly influenced in vivo plasma profile. The in vivo absorption study in pigs indicated that Cmax (14.54 µg/mL) was significantly higher in FF-NE, 3.42 times higher than the marketed formulation. In comparison with the control group, the relative bioavailability of formulated nanoemulsion was up to 134.5%. Assessment of bioequivalence using log-transformed data showed that the 90% confidence intervals (90% CI) of Cmax and AUC0-∞ were 2.48-4.60 and 1.21-1.72, respectively.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Nanotechnology , Swine/blood , Thiamphenicol/analogs & derivatives , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/blood , Anti-Bacterial Agents/chemistry , Area Under Curve , Biological Availability , Cross-Over Studies , Dosage Forms , Female , Half-Life , Male , Particle Size , Therapeutic Equivalency , Thiamphenicol/administration & dosage , Thiamphenicol/blood , Thiamphenicol/chemistry , Thiamphenicol/pharmacokinetics
11.
Genet Mol Res ; 14(4): 14189-95, 2015 Nov 13.
Article in English | MEDLINE | ID: mdl-26600476

ABSTRACT

This study aimed to investigate the expressional profile of interleukin-6 (IL-6) in articular cartilage bone of osteoarthritis (OA) patients and its correlation with OA. A total of 30 articular cartilage bone samples from knee OA patients, which were collected by knee arthroscopy or articular surgery, comprised the study group, and 30 samples of normal articular cartilage tissue comprised the control group. Both mRNA (messenger ribonucleic acid) and protein levels of IL-6 and matrix metalloproteinase-9 (MMP-9) were measured and compared, and a correlation analysis was performed between the two. The integral optical density (IOD) values of MMP-9 and IL-6 proteins in the study group were 9.21 ± 3.22 and 8.94 ± 3.17, respectively; these were significantly higher (P < 0.05) than those in the control group at 3.14 ± 1.48 and 6.64 ± 1.53, respectively. The IOD values of mRNA transcripts for MMP-9 and IL-6 in the study group were 8.31 ± 2.28 and 8.78 ± 3.43, respectively; these were significantly higher than the values in the control group at 3.52 ± 1.37 and 5.21 ± 1.72 (P < 0.05), respectively. Further, the correlation analysis revealed significantly positive relationships for both protein (r = 0.434, P = 0.001) and mRNA (r = 0.413, P = 0.002) levels between MMP-9 and IL-6. In conclusion, articular cartilage tissues in knee OA patients have higher levels of MMP-9 and IL-6 expression, and these may play a synergistic role in OA pathogenesis.


Subject(s)
Cartilage, Articular/metabolism , Cartilage, Articular/pathology , Interleukin-6/biosynthesis , Osteoarthritis, Knee/metabolism , Osteoarthritis, Knee/pathology , Adult , Aged , Case-Control Studies , Female , Genetic Association Studies , Humans , Interleukin-6/genetics , Male , Matrix Metalloproteinase 3/genetics , Matrix Metalloproteinase 3/metabolism , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/metabolism , Middle Aged , Osteoarthritis, Knee/genetics , RNA, Messenger/genetics , Transcriptome
12.
Sci Rep ; 5: 10908, 2015 Jun 03.
Article in English | MEDLINE | ID: mdl-26039972

ABSTRACT

Silicon batteries have attracted much attention in recent years due to their high theoretical capacity, although a rapid capacity fade is normally observed, attributed mainly to volume expansion during lithiation. Here, we report for the first time successful synthesis of Si/void/SiO2/void/C nanostructures. The synthesis strategy only involves selective etching of SiO2 in Si/SiO2/C structures with hydrofluoric acid solution. Compared with reported results, such novel structures include a hard SiO2-coated layer, a conductive carbon-coated layer, and two internal void spaces. In the structures, the carbon can enhance conductivity, the SiO2 layer has mechanically strong qualities, and the two internal void spaces can confine and accommodate volume expansion of silicon during lithiation. Therefore, these specially designed dual yolk-shell structures exhibit a stable and high capacity of 956 mA h g(-1) after 430 cycles with capacity retention of 83%, while the capacity of Si/C core-shell structures rapidly decreases in the first ten cycles under the same experimental conditions. The novel dual yolk-shell structures developed for Si can also be extended to other battery materials that undergo large volume changes.

13.
Clin Microbiol Infect ; 21(3): 236-41, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25658536

ABSTRACT

Nontuberculous mycobacteria infection is a growing global concern, but data from Asia are limited. This study aimed to describe the distribution and antibiotic susceptibility profiles of rapidly growing mycobacterium (RGM) isolates in Singapore. Clinical RGM isolates with antibiotic susceptibility tests performed between 2006 and 2011 were identified using microbiology laboratory databases and minimum inhibitory concentrations of amikacin, cefoxitin, clarithromycin, ciprofloxacin, doxycycline, imipenem, linezolid, moxifloxacin, sulfamethoxazole or trimethoprim-sulfamethoxazole, tigecycline and tobramycin were recorded. Regression analysis was performed to detect changes in antibiotic susceptibility patterns over time. A total of 427 isolates were included. Of these, 277 (65%) were from respiratory specimens, 42 (10%) were related to skin and soft tissue infections and 36 (8%) were recovered from blood specimens. The two most common species identified were Mycobacterium abscessus (73%) and Mycobacterium fortuitum group (22%), with amikacin and clarithromycin being most active against the former, and quinolones and trimethoprim-sulfamethoxazole against the latter. Decreases in susceptibility of M. abscessus to linezolid by 8.8% per year (p 0.001), M. fortuitum group to imipenem by 9.5% per year (p 0.023) and clarithromycin by 4.7% per year (p 0.033) were observed. M. abscessus in respiratory specimens is the most common RGM identified in Singapore. Antibiotic options for treatment of RGM infections are increasingly limited.


Subject(s)
Mycobacterium Infections/epidemiology , Mycobacterium Infections/microbiology , Mycobacterium , Anti-Bacterial Agents/pharmacology , Cohort Studies , Drug Resistance, Bacterial , History, 21st Century , Humans , Microbial Sensitivity Tests , Mycobacterium/classification , Mycobacterium/drug effects , Mycobacterium/genetics , Mycobacterium/isolation & purification , Mycobacterium Infections/history , Singapore/epidemiology
14.
Plant Dis ; 98(4): 566, 2014 Apr.
Article in English | MEDLINE | ID: mdl-30708710

ABSTRACT

Eggplant (Solanum melongena L.) is an important vegetable crop that has significant economic value in northern regions of China, especially in Liaoning Province. In April 2013, a leaf spot was discovered on the eggplant cultivar 706 in ten 1-ha commercial greenhouses in Huludao, Liaoning Province, with 30% of the eggplants infected, resulting in reduced eggplant yield and quality. By July 2013, disease incidence was 35%. Spots were found mainly on the leaves. At the early stage of infection, small, chlorotic spots appeared on leaves and gradually expanded into brown, irregular spots with a diameter of 1 to 7 mm. Dark green mold developed in the spots on both sides of the leaves at high humidity, and the spots led to leaf yellowing and defoliation. Conidiophores in the lesions were straight or slightly flexuous with 1 to 7 septa, brown and smooth, with typical swellings at the junction of septa, and 45 to 670 × 3.0 to 5.3 µm. Conidia were oval or obpyriform with a smooth surface, brown or dark brown, with 0 to 2 septa and 5.5 to 14.8 × 2.5 to 4.0 µm. The pathogen was consistent morphologically with Cladosporium oxysporum (1). To identify the pathogen, leaf pieces (3 to 5 mm2) taken from the edge of lesions so that each leaf section included both infected and healthy leaf tissue, were surface-disinfested in 75% ethanol for 30 s, then transferred to a 0.1% aqueous mercuric chloride solution for 30 to 60 s, and rinsed with sterilized water three times. The sections were cultured on potato dextrose agar (PDA) at 25°C in the dark for 7 days. Three pure cultures were obtained from single spores. The conidia on PDA were oval or obpyriform, and 5.4 to 14.7 × 2.4 to 4.2 µm with 0 to 1 septa, and were smaller than the conidia examined directly from infected eggplant leaves. Two isolates were grown on synthetic nutrient agar (SNA) in slide cultures. The conidiophores on SNA were straight or slightly flexuous with swellings at the junctions of septa. On the grounds of these morphological characteristics, the pathogen was identified as C. oxysporum (1,3). For DNA extraction, cultures were grown in potato dextrose broth and the internal transcribed spacer (ITS) region of ribosomal DNA (rNDA) was amplified using primers ITS1 and ITS4 (2). Sequence analysis showed that the ITS sequences of the two isolates were 99% identical to that of C. oxysporum (GenBank Accession No. EF029816). Two isolates were tested for pathogenicity on eggplant using 1 × 107 conidia/ml in sterilized water atomized onto each of six 7-week-old plants of the cultivar Xi'an Green Eggplant. Sterilized water was applied similarly to another six plants as the control treatment. The plants were incubated at 25°C with 85% relative humidity for 8 to 10 days. After 10 days, light brown, irregular spots were found on inoculated leaves, whereas no symptoms were observed on control plants. The pathogen was re-isolated from lesions on inoculated plants but not from control plants. The re-isolates were confirmed to be C. oxysporum based on morphological characteristics. The pathogenicity test was repeated and the same results obtained. Therefore, the pathogen causing leaf spot on eggplant in these greenhouses was identified as C. oxysporum. This is the first report of C. oxysporum causing leaf spot on greenhouse eggplant in China. C. oxysporum is a known pathogen of pepper and tomato. Additional studies are needed to provide management recommendations for this pathogen on Solanaceae crops. References: (1) K. Bensch et al. Stud. Mycol. 67:1, 2010. (2) Q. Li and G. Wang. Microbiol. Res. 164:233, 2009. (3) W. T. H. Peregrine and K. B. Ahmad. Phytopathol. Pap. 27:1, 1982.

15.
Exp Clin Endocrinol Diabetes ; 121(8): 488-93, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23864495

ABSTRACT

OBJECTIVES: Numerous reports have suggested that thyroid-stimulating hormone (TSH) contributes to insulin resistance in adipocytes by directly stimulating the production of adipokines, such as tumor necrosis factor α (TNF-α). The objective of this study was to clarify how TSH regulates TNF-α secretion in 3T3-L1 adipocytes and to determine which cell signaling pathways were involved. METHODS: Mouse 3T3-L1 preadipocytes were differentiated into adipocytes and then exposed to 0.1 mIU/ml bovine TSH. The optimal treatment duration was determined by measuring the TNF-α concentration in the medium by ELISA. Thereafter, adipocytes were treated with 0.01, 0.1, and 1.0 mIU/ml bovine TSH, and the optimal TSH dose was determined. To decrease TSHR expression, TSHR shRNA was transfected into adipocytes, and the silencing was confirmed by Western blotting. The TSH signaling pathways responsible for regulating TNF-α secretion were studied. Phospho-NF-κBp65 Ser276 was quantified by Western blotting, and co-immunopreci-pitations were performed to detect the formation of the IκBα/PKAc complex. RESULTS: TNF-α secretion from adipocytes peaked 4 h after TSH treatment. TSH induced TNF-α secretion in a dose-dependent manner, which was almost completely inhibited by TSHR shRNA. There was a significant positive correlation between phospho-NF-κBp65 Ser276 levels and TNF-α secretion. H89, a cAMP-dependent protein kinase A inhibitor, significantly inhibited the effects of TSH. Bovine TSH and forskolin, which increases intracellular cAMP, simultaneously stimulated TNF-α secretion. The IκBα/PKAc complex could be detected in TSH-treated cells, but complex formation was inhibited by H89. CONCLUSIONS: TSH stimulated the cAMP-PKA pathway in 3T3-L1 adipocytes to increase TNF-α secretion.


Subject(s)
Adipocytes/drug effects , Cyclic AMP-Dependent Protein Kinases/physiology , Thyrotropin/pharmacology , Tumor Necrosis Factor-alpha/metabolism , 3T3-L1 Cells , Adipocytes/metabolism , Animals , Mice , NF-kappa B/metabolism , RNA, Small Interfering/pharmacology , Receptors, Thyrotropin/genetics , Signal Transduction/drug effects , Signal Transduction/physiology
16.
J Endocrinol Invest ; 36(9): 745-52, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23580127

ABSTRACT

BACKGROUND: The processing of proprotein convertase (PC)-mediated neuropeptide plays a very important role in carcinogenesis and tumor proliferation. AIM: To investigate proneuropeptide processing mechanism in tumorigenesis and tumor proliferation. MATERIALS AND METHODS: The expression and processing profiles of PC1, carboxypeptidase E (CPE), PC2, GHRH, or neuropeptide Y (NPY) gene and protein level were investigated between 42 human breast tumor tissues and 21 tumor-adjacent normal tissues. RESULTS: Gene analyses indicated that the proPC1, CPE, or preproNPY gene had higher expression in the breast tumor tissues, whereas the proPC2 or preproGHRH gene showed lower expression in the tissues. Protein analyses showed that the proPC1, PC1, CPE, GHRH, and preproNPY proteins were upregulated in the tumor tissues, whereas the proPC2, PC2, preproGHRH, and NPY proteins were down-regulated in them. The tissue results were highly corroborated with the serum data from the tumor patients and healthy women. CONCLUSIONS: The higher PC1 and CPE expressions as well as the transformation of more proGHRH into active GHRH peptide suggest stronger PC1/CPE-mediated neuropeptide processing in the tumor, whereas the lower PC2 expression as well as the transformation of less proNPY into active NPY peptide suggests a weak PC2-mediated processing in it. The alterations of the convertase expressions and processing show that there is a differential proprotein processing system in the tumor, which leads to the abnormal distributions of species, ratio, and concentration of (pro)peptide(s) in the microenvironment of cells. The latter may contribute to cancer progression.


Subject(s)
Adenocarcinoma/metabolism , Breast Neoplasms/metabolism , Carboxypeptidase H/metabolism , Proprotein Convertase 1/metabolism , Proprotein Convertase 2/metabolism , Proprotein Convertases/metabolism , Adenocarcinoma/genetics , Adult , Breast Neoplasms/genetics , Carboxypeptidase H/genetics , Female , Growth Hormone-Releasing Hormone/genetics , Growth Hormone-Releasing Hormone/metabolism , Humans , Immunohistochemistry , Middle Aged , Proprotein Convertase 1/genetics , Proprotein Convertase 2/genetics , Proprotein Convertases/genetics , Protein Precursors/genetics , Protein Precursors/metabolism
17.
Int J Tuberc Lung Dis ; 16(12): 1686-91, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23131270

ABSTRACT

BACKGROUND: Tuberculosis (TB) of the cervical lymph nodes may mimic lymphoma. OBJECTIVE: To evaluate multidetector-row computed tomographic (MDCT) imaging criteria for differentiating between the two diseases. MATERIALS AND METHODS: We retrospectively reviewed the anatomical distribution and CT enhancement patterns of the nodes in 81 patients, 27 (33%) with untreated TB and 54 (67%) with untreated lymphomas involving cervical lymph nodes. Of the patients with lymphomas, 19 (35%) had Hodgkin's disease and 35 (65%) had non-Hodgkin's lymphoma. RESULTS: TB predominantly involved the upper cervical nodes. The supraclavicula fossa nodes on MDCT were involved more often in Hodgkin's disease (n = 15, 79%) and non-Hodgkin's lymphoma (n = 25, 71%) than in TB (n = 3, 11%). Tuberculous lymphadenopathy commonly showed peripheral enhancement, frequently with a multilocular appearance. Peripheral enhancement was significantly more frequent in TB (n = 19, 70%) than in Hodgkin's disease (n = 1, 5%) and non-Hodgkin's lymphoma (n = 1, 3%), but homogeneous enhancement was less common in the TB group. CONCLUSION: Our findings indicate that a specific enhancement pattern of lymphadenopathy seen on MDCT was useful in differentiating between untreated TB and lymphomas of the cervical lymph nodes.


Subject(s)
Diagnosis, Differential , Hodgkin Disease/diagnostic imaging , Lymph Nodes/diagnostic imaging , Lymphoma, Non-Hodgkin/diagnostic imaging , Multidetector Computed Tomography , Tuberculosis, Lymph Node/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Biopsy , Chi-Square Distribution , Child , Child, Preschool , Female , Hodgkin Disease/pathology , Humans , Infant , Lymph Nodes/pathology , Lymphoma, Non-Hodgkin/pathology , Male , Middle Aged , Neck , Predictive Value of Tests , Retrospective Studies , Sensitivity and Specificity , Tuberculosis, Lymph Node/pathology , Young Adult
18.
Eur J Clin Microbiol Infect Dis ; 31(11): 3041-6, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22678350

ABSTRACT

As data on procalcitonin utility in antibiotics discontinuation [under an antimicrobial stewardship program (ASP)] in patients with malignancies are lacking, we aimed to evaluate the utility of procalcitonin in an ASP in patients with malignancies. We conducted a retrospective review of the ASP database of all patients with malignancies in whom at least one procalcitonin level was taken and our ASP had recommended changes in carbapenem regimen, from January to December 2011. We compared clinical outcomes between two groups of patients: patients whose physicians accepted and those whose physicians rejected ASP interventions. There were 749 carbapenem cases reviewed. Ninety-nine were suggested to either de-escalate, discontinue antibiotics, or narrow the spectrum of empiric treatment, based on procalcitonin trends. While there was no statistical difference in the mortality within 30 days post-ASP intervention (accepted: 8/65 patients vs. rejected: 9/34 patients; p = 0.076), the median duration of carbapenem therapy was significantly shorter (5 vs. 7 days; p = 0.002). Procalcitonin use safely facilitates decisions on antibiotics discontinuation and de-escalation in patients with malignancies in the ASP.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacterial Infections/diagnosis , Bacterial Infections/drug therapy , Biomarkers/blood , Calcitonin/blood , Drug Monitoring/methods , Neoplasms/complications , Protein Precursors/blood , Adult , Aged , Aged, 80 and over , Calcitonin Gene-Related Peptide , Carbapenems/therapeutic use , Female , Humans , Male , Middle Aged , Retrospective Studies , Survival Analysis , Time Factors , Treatment Outcome , Young Adult
19.
Clin Radiol ; 67(9): 877-83, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22483945

ABSTRACT

AIM: To determine the specific imaging criteria on contrast-enhanced multidetector computed tomography (MDCT) for differentiating between tuberculosis and lymphoma in mediastinal lymph nodes. MATERIALS AND METHODS: The anatomical distribution and enhancement patterns of mediastinal lymph nodes on contrast-enhanced MDCT were reviewed in 37 patients with tuberculosis and 54 patients with lymphoma. Of the patients with lymphoma, 18 had Hodgkin's disease and 36 had non-Hodgkin's lymphoma. RESULTS: Region 10R was involved more often in tuberculosis than in Hodgkin's disease and non-Hodgkin's lymphoma. Region 6 had a higher tendency to be affected in Hodgkin's disease and non-Hodgkin's lymphoma compared with tuberculosis. Tuberculosis showed peripheral enhancement in 78% of cases, frequently with a multilocular appearance, compared to Hodgkin's disease and non-Hodgkin's lymphoma, which showed peripheral enhancement in only 6 and 3% of cases, respectively. Homogeneous enhancement was more commonly seen in lymphoma (83% for Hodgkin's disease, and 83% for non-Hodgkin's lymphoma) than in tuberculosis (8%). In the determination of tuberculosis, results showed that when a peripheral enhancement pattern was seen, sensitivity was 78%, specificity was 96%, and accuracy was 89%. In the determination of lymphoma, results showed that when a homogeneous enhancement pattern was seen, sensitivity was 83%, specificity was 92%, and accuracy was 87%. CONCLUSION: The findings of the present study indicate that specific anatomical distribution and enhancement patterns of lymphadenopathy shown on contrast-enhanced MDCT can be useful in differentiating tuberculosis from lymphoma of mediastinal lymph nodes.


Subject(s)
Contrast Media , Iohexol , Lymphoma/diagnostic imaging , Mediastinum/diagnostic imaging , Multidetector Computed Tomography/methods , Tuberculosis/diagnostic imaging , Adolescent , Adult , Diagnosis, Differential , Female , Humans , Lymph Nodes/diagnostic imaging , Male , Middle Aged , Observer Variation , Radiographic Image Enhancement/methods , Reproducibility of Results , Sensitivity and Specificity , Young Adult
20.
Clin Radiol ; 67(8): 746-53, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22341184

ABSTRACT

AIM: To investigate the correlation between vascular endothelial cell growth factor (VEGF) expression and first-pass perfusion parameters at multidetector computed tomography (MDCT) using a low-dose technique, and to determine how to discriminate VEGF positivity from VEGF negativity by perfusion CT in oesophageal squamous cell carcinomas. MATERIALS AND METHODS: Thirty-two patients with oesophageal squamous cell carcinomas underwent first-pass perfusion with 64-section MDCT at 50 mAs. Perfusion parameters, including perfusion, peak enhanced density (PED), time to peak (TTP), and blood volume (BV), were measured. Postoperative specimens were assessed for VEGF expression. Correlation tests were performed to determine the associations between each CT perfusion parameter and VEGF expression. The cut-off values of perfusion parameters were obtained statistically to discriminate VEGF positivity from VEGF negativity. RESULTS: Mean perfusion, PED, TTP, and BV were 38.47 ± 30.26 ml/min/ml, 24.68 ± 9.65 HU, 28.35 ± 9.03 s, and 11.82 ± 6.06 ml/100 g, respectively. PED or BV were significantly higher in the VEGF-positive group than in the VEGF-negative group (all p < 0.05), but no significant difference in perfusion or TTP was found between the VEGF-positive and VEGF-negative groups (all p > 0.05). In VEGF positivity, PED and BV were correlated with VEGF expression (r = 0.576 and 0.765, respectively; all p < 0.05), whereas perfusion and TTP were not (r = 0.361 and 0.239, respectively; all p > 0.05). A threshold of BV (10.23 ml/100 g) achieved a sensitivity of 94.4%, and a specificity of 92.9% for discriminating VEGF positivity from VEGF negativity. CONCLUSION: BV could reflect tumour VEGF expression, and could be an indicator for evaluating angiogenesis in oesophageal tumours.


Subject(s)
Carcinoma, Squamous Cell/blood supply , Carcinoma, Squamous Cell/diagnostic imaging , Esophageal Neoplasms/blood supply , Esophageal Neoplasms/diagnostic imaging , Multidetector Computed Tomography/methods , Neovascularization, Pathologic/diagnostic imaging , Vascular Endothelial Growth Factor A/metabolism , Adult , Aged , Aged, 80 and over , Blood Volume/physiology , Carcinoma, Squamous Cell/metabolism , Contrast Media , Esophageal Neoplasms/metabolism , Female , Humans , Iohexol/analogs & derivatives , Male , Middle Aged , Neovascularization, Pathologic/metabolism , Prospective Studies , Radiographic Image Interpretation, Computer-Assisted/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...